Screening of Cationic Short Peptide RKIIIRW and Its Antimelanoma Nano Delivery System
Biomacromolecules · 10.08.2026 · 27 (8) · 5195-5211
DOI: 10.1021/acs.biomac.6c00398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 01.07.2026. Verfasst von Dayang Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Institute of Biomedical Materials and Engineering, Qingd…. Hauptthemen laut MEDLINE: Nanoparticles, Melanoma, Experimental, Drug Delivery Systems, Peptides. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Planing Project of South District of Qingdao City, National Key R&D Program of China.
Abstract (Originalsprache)
Melanoma is one of the most lethal cancers in the clinic; cationic peptides have shown great potential in the treatment of melanoma. The large pore volume and high specific surface area of mesoporous silica nanoparticles (MSNs) allow for efficient loading of drugs, while surface-functionalized MSNs can further improve drug stability and carrier targeting. Polydopamine (PDA) coating is an effective surface modification method that provides an additional protective layer to prevent premature drug release during delivery and can prolong the treatment time. Hyaluronic acid (HA) is a commonly used tumor-targeting molecule that binds to HA receptors on the surface of tumor cells, thereby facilitating drug internalization and enhancing the therapeutic effect of the drug. In this paper, the cationic short peptide RKIIIRW, which can effectively inhibit B16F10 cells, was successfully screened by solid-phase synthesis combined with MTT assay and cell membrane chromatography. By combining the cationic short peptide RKIIIRW with MSNs and further surface modification with PDA coating and HA targeting molecules, a nanodrug delivery system with targeted and controllable release characteristics was prepared. This drug-delivery system enhances the efficacy of cationic short peptides while minimizing side effects, offering a more effective therapeutic strategy for melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Institute of Biomedical Materials and Engineering, Qingdao University, Qingdao266071, China.
- School of Materials Science and Engineering, Shandong University of Technology, Zibo255000, China.
- College of Chemistry, Chemical Engineering and Materials Science, Zaozhuang University, Zaozhuang277160, China.
ORCID-Profile: Bing Yu
Förderung
- National Natural Science Foundation of China
- Science and Technology Planing Project of South District of Qingdao City
- National Key R&D Program of China
- Qingdao Science and Technology for People's Benefit Demonstration Project
- Exploration project of the State Key Laboratory of BioFibers and EcoTextiles of Qingdao University
- Medical Plus Key Project of Qingdao University
- Shandong Provincial Natural Science Foundation
Zitieren
APA
Wang, D., Shi, P., Ye, J., Wang, Z., Cong, H., & Yu, B. (2026). Screening of Cationic Short Peptide RKIIIRW and Its Antimelanoma Nano Delivery System. Biomacromolecules, 27(8), 5195-5211. https://doi.org/10.1021/acs.biomac.6c00398
Vancouver
Wang D, Shi P, Ye J, Wang Z, Cong H, Yu B. Screening of Cationic Short Peptide RKIIIRW and Its Antimelanoma Nano Delivery System. Biomacromolecules. 2026;27(8):5195-5211. doi:10.1021/acs.biomac.6c00398
BibTeX
@article{Wang2026,
author = {Wang, Dayang and Shi, Pengbao and Ye, Jiashuo and Wang, Ziyan and Cong, Hailin and Yu, Bing},
title = {Screening of Cationic Short Peptide RKIIIRW and Its Antimelanoma Nano Delivery System},
journal = {Biomacromolecules},
year = {2026},
volume = {27},
number = {8},
pages = {5195--5211},
doi = {10.1021/acs.biomac.6c00398}
}
EUVIMED